Imagene Bio Reports Q2 2026 Financial Results and Appoints New CFO
The biotech company reported $136.2 million in cash and aims for funding into early 2028.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day